← Open Payments lookup

SANJYOT BHADKAMKAR: Open Payments

NPI 1457778961 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,935 in 152 payments from 38 companies in 2025. Trend: 2023 $2,923 · 2024 $4,236 · 2025 $3,935

Food & beverage: $2,935Long term medical supply or device loan: $1,000
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation22$1,217
AstraZeneca Pharmaceuticals LP13$243
Merck Sharp & Dohme LLC12$238
Janssen Biotech, Inc.10$192
PFIZER INC.10$187
Regeneron Healthcare Solutions, Inc.6$141
Celgene Corporation6$140
Daiichi Sankyo Inc.6$138
Takeda Pharmaceuticals U.S.A., Inc.3$132
E.R. Squibb & Sons, L.L.C.6$116

Products named: KISQALI, KEYTRUDA, LIBTAYO, OPDIVO, REBLOZYL, IMFINZI, VERZENIO, ERLEADA.

Industry payments across AL — which companies pay providers there.